Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip
Authors
Keywords
-
Journal
BioChip Journal
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-17
DOI
10.1007/s13206-023-00125-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Customized Multilayered Tissue-on-a-Chip (MToC) to Simulate Bacillus Calmette–Guérin (BCG) Immunotherapy for Bladder Cancer Treatment
- (2022) Seungjin Lee et al. BioChip Journal
- Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
- (2021) Antonio Lopez-Beltran et al. Cancers
- Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette–Guérin
- (2021) Jung Hoon Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
- (2021) Arjun V Balar et al. LANCET ONCOLOGY
- Hsa_circ_0000652 Aggravates Inflammation by Activation of Macrophages and Enhancement of OX40/OX40L Interaction in Ankylosing Spondylitis
- (2021) Minkai Song et al. Frontiers in Cell and Developmental Biology
- KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC
- (2020) Ashish M Kamat et al. Future Oncology
- Treatment of muscle‐invasive and advanced bladder cancer in 2020
- (2020) Vaibhav G. Patel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy
- (2018) Mathieu F. Chevalier et al. EUROPEAN UROLOGY
- In vitro immunotherapy potency assays using real-time cell analysis
- (2018) Fabio Cerignoli et al. PLoS One
- Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer
- (2018) Yonghua Wang et al. OncoTargets and Therapy
- Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy
- (2018) Wen Cheng et al. Oncogenesis
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Modulating the Internalization of Bacille Calmette-Guérin by Cathelicidin in Bladder Cancer Cells
- (2015) Se Young Choi et al. UROLOGY
- Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guérin (BCG) immunotherapy
- (2010) A. M. JACKSON et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Discontinuance of Bacille Calmette-Guérin Instillation Therapy for Nonmuscle-invasive Bladder Cancer Has Negative Effect on Tumor Recurrence
- (2009) Toshikazu Takeda et al. UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More